|
Market Closed -
NYSE
04:00:00 01/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 21.01 USD | +0.43% |
|
-10.67% | -32.23% |
| 08-14 | Oppenheimer Adjusts Pelthos Therapeutics PT to $64 From $66, Maintains Outperform Rating | MT |
| 08-13 | Pelthos Therapeutics Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
Chart: Technical Analysis
NYSEUSD
| Markets | Quality | ||
|---|---|---|---|
NYSE
| PTHS | Delayed | |
CBOE
| PTHS | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Neutral |
| Resistance | 24.08 | 24.08 | 34.4 |
| Spread/Res. | -12.75% | -12.75% | -38.92% |
| Spread/Supp. | +8.19% | +8.19% | +2.99% |
| Support | 19.42 | 19.42 | 20.4 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- PTHS Stock
- Charts Pelthos Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
